# Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction

> **NCT06964607** · — · COMPLETED · sponsor: **Tanta University** · enrollment: 80 (actual)

## Conditions studied

- Sodium-glucose Cotransporter 2
- Inhibitors
- Clinical Outcome
- Left Ventricule
- Acute Myocardial Infarction

## Interventions

- **DRUG:** Sodium-glucose cotransporter-2 Inhibitors
- **DRUG:** Conventional treatment

## Key facts

- **NCT ID:** NCT06964607
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-04-01
- **Primary completion:** 2024-04-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06964607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06964607, "Impact of Sodium Glucose Co-transporter 2-Inhibitors on Clinical Outcome and Left Ventricular Function in Patients Presented by Acute Myocardial Infarction". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06964607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*